A detailed history of Bokf, Na transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bokf, Na holds 2 shares of SRPT stock, worth $228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$228
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$113.33 - $163.85 $1,586 - $2,293
-14 Reduced 87.5%
2 $0
Q1 2024

May 15, 2024

BUY
$93.7 - $141.53 $1,311 - $1,981
14 Added 700.0%
16 $2,000
Q4 2023

Feb 14, 2024

SELL
$67.31 - $124.76 $807 - $1,497
-12 Reduced 85.71%
2 $0
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $1,435 - $1,730
14 New
14 $1,000
Q1 2023

May 11, 2023

BUY
$117.53 - $155.99 $15,513 - $20,590
132 New
132 $18,000
Q1 2021

Apr 21, 2021

SELL
$72.25 - $168.95 $2.12 Million - $4.95 Million
-29,288 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$125.56 - $178.74 $1.14 Million - $1.63 Million
9,114 Added 45.18%
29,288 $4.99 Million
Q3 2020

Oct 30, 2020

SELL
$127.12 - $172.34 $387,461 - $525,292
-3,048 Reduced 13.13%
20,174 $2.83 Million
Q2 2020

Aug 12, 2020

SELL
$93.0 - $171.7 $94,209 - $173,932
-1,013 Reduced 4.18%
23,222 $3.72 Million
Q1 2020

May 13, 2020

BUY
$82.38 - $131.64 $418,325 - $668,467
5,078 Added 26.51%
24,235 $2.37 Million
Q4 2019

Feb 12, 2020

BUY
$76.53 - $135.58 $1.47 Million - $2.6 Million
19,157 New
19,157 $2.47 Million
Q3 2019

Nov 13, 2019

SELL
$72.81 - $156.91 $1.92 Million - $4.14 Million
-26,415 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $526,713 - $713,253
4,694 Added 21.61%
26,415 $4.01 Million
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $2.03 Million - $2.89 Million
19,035 Added 708.67%
21,721 $2.59 Million
Q4 2018

Feb 13, 2019

SELL
$97.32 - $148.76 $1.07 Million - $1.64 Million
-11,045 Reduced 80.44%
2,686 $293,000
Q3 2018

Nov 13, 2018

BUY
$115.31 - $161.51 $1.58 Million - $2.22 Million
13,731 New
13,731 $2.22 Million
Q1 2018

May 14, 2018

SELL
$54.02 - $82.27 $2.3 Million - $3.51 Million
-42,631 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$47.64 - $56.75 $364,874 - $434,648
7,659 Added 21.9%
42,631 $2.37 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $1.25 Million - $1.65 Million
34,972
34,972 $1.59 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.